# Temocillin Pharmacokinetic in Hemodialysis

> **NCT02285075** · PHASE4 · COMPLETED · sponsor: **AZ Sint-Jan AV** · enrollment: 16 (actual)

## Conditions studied

- Gram-Negative Bacterial Infections
- Renal Failure Chronic Requiring Hemodialysis

## Interventions

- **DRUG:** temocillin PK/PD in haemodialysis

## Key facts

- **NCT ID:** NCT02285075
- **Lead sponsor:** AZ Sint-Jan AV
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-06
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2016-01-05

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02285075

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02285075, "Temocillin Pharmacokinetic in Hemodialysis". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02285075. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*